Research ExplorerPublicationsThe German Competence Network on Atrial Fibrillation (AFNET)

The German Competence Network on Atrial Fibrillation (AFNET)

Standard

The German Competence Network on Atrial Fibrillation (AFNET). / Breithardt, Günter; Dobrev, Dobromir; Doll, Nicolas; Goette, Andreas; Hoffmann, Boris; Kirchhof, Paulus; Köster, Ilka; Kuck, Karl-Heinz; Leute, Angelika; Meinertz, Thomas; Näbauer, Michael; Oeff, Michael; Ravens, Ursula; Schuchert, Andreas; Sprenger, Claudia; Steinbeck, Gerhard; Willems, Stephan.

In: HERZ, Vol. 33, No. 8, 12.2008, p. 548-555.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Breithardt, G, Dobrev, D, Doll, N, Goette, A, Hoffmann, B, Kirchhof, P, Köster, I, Kuck, K-H, Leute, A, Meinertz, T, Näbauer, M, Oeff, M, Ravens, U, Schuchert, A, Sprenger, C, Steinbeck, G & Willems, S 2008, 'The German Competence Network on Atrial Fibrillation (AFNET)', HERZ, vol. 33, no. 8, pp. 548-555. https://doi.org/10.1007/s00059-008-3177-2

APA

Breithardt, G., Dobrev, D., Doll, N., Goette, A., Hoffmann, B., Kirchhof, P., Köster, I., Kuck, K-H., Leute, A., Meinertz, T., Näbauer, M., Oeff, M., Ravens, U., Schuchert, A., Sprenger, C., Steinbeck, G., & Willems, S. (2008). The German Competence Network on Atrial Fibrillation (AFNET). HERZ, 33(8), 548-555. https://doi.org/10.1007/s00059-008-3177-2

Vancouver

Breithardt G, Dobrev D, Doll N, Goette A, Hoffmann B, Kirchhof P et al. The German Competence Network on Atrial Fibrillation (AFNET). HERZ. 2008 Dec;33(8):548-555. https://doi.org/10.1007/s00059-008-3177-2

Bibtex

@article{1721b68e9420438499117c64d539c293,
title = "The German Competence Network on Atrial Fibrillation (AFNET)",
abstract = "The German Competence Network on Atrial Fibrillation (AFNET) is an interdisciplinary national research network funded by the Federal Ministry of Education and Research (BMBF) since 2003. The AFNET aims at improving treatment of atrial fibrillation (AF), the most frequent sustained arrhythmia of the heart. The AFNET has established a nationwide patient registry on manifestation, diagnostics, and therapy of AF in Germany. The data analyzed to date demonstrate that patients with AF are likely to have multiple comorbidities (hypertension, valvular heart disease, coronary artery disease, diabetes mellitus) and an advanced age. Regarding oral anticoagulation, guideline adherence is very high. Basic research has identified specific changes in atrial tissue during AF-induced remodeling providing the rationale for novel therapeutic interventions. Clinical trials are being carried out to optimize pharmacological and nonpharmacological treatments. The ANTIPAF trial is designed to prove that angiotensin II receptor blockers reduce the incidence of paroxysmal AF. The Flec-SL trial tests the efficacy of a short-term treatment with antiarrhythmic drugs after cardioversion. The Gap-AF trial investigates the impact of complete pulmonary vein (PV) isolation versus incomplete circumferential PV ablation on AF recurrences. The effect of preventive pacing on the recurrence of paroxysmal AF is studied in the BACE-PACE trial.",
keywords = "Atrial Fibrillation/diagnosis, Community Networks/organization & administration, Germany/epidemiology, Humans, National Health Programs/organization & administration, Population Surveillance, Practice Patterns, Physicians'/statistics & numerical data, Professional Competence/statistics & numerical data, Registries",
author = "G{\"u}nter Breithardt and Dobromir Dobrev and Nicolas Doll and Andreas Goette and Boris Hoffmann and Paulus Kirchhof and Ilka K{\"o}ster and Karl-Heinz Kuck and Angelika Leute and Thomas Meinertz and Michael N{\"a}bauer and Michael Oeff and Ursula Ravens and Andreas Schuchert and Claudia Sprenger and Gerhard Steinbeck and Stephan Willems",
year = "2008",
month = dec,
doi = "10.1007/s00059-008-3177-2",
language = "English",
volume = "33",
pages = "548--555",
journal = "HERZ",
issn = "0340-9937",
publisher = "Urban und Vogel",
number = "8",

}

RIS

TY - JOUR

T1 - The German Competence Network on Atrial Fibrillation (AFNET)

AU - Breithardt, Günter

AU - Dobrev, Dobromir

AU - Doll, Nicolas

AU - Goette, Andreas

AU - Hoffmann, Boris

AU - Kirchhof, Paulus

AU - Köster, Ilka

AU - Kuck, Karl-Heinz

AU - Leute, Angelika

AU - Meinertz, Thomas

AU - Näbauer, Michael

AU - Oeff, Michael

AU - Ravens, Ursula

AU - Schuchert, Andreas

AU - Sprenger, Claudia

AU - Steinbeck, Gerhard

AU - Willems, Stephan

PY - 2008/12

Y1 - 2008/12

N2 - The German Competence Network on Atrial Fibrillation (AFNET) is an interdisciplinary national research network funded by the Federal Ministry of Education and Research (BMBF) since 2003. The AFNET aims at improving treatment of atrial fibrillation (AF), the most frequent sustained arrhythmia of the heart. The AFNET has established a nationwide patient registry on manifestation, diagnostics, and therapy of AF in Germany. The data analyzed to date demonstrate that patients with AF are likely to have multiple comorbidities (hypertension, valvular heart disease, coronary artery disease, diabetes mellitus) and an advanced age. Regarding oral anticoagulation, guideline adherence is very high. Basic research has identified specific changes in atrial tissue during AF-induced remodeling providing the rationale for novel therapeutic interventions. Clinical trials are being carried out to optimize pharmacological and nonpharmacological treatments. The ANTIPAF trial is designed to prove that angiotensin II receptor blockers reduce the incidence of paroxysmal AF. The Flec-SL trial tests the efficacy of a short-term treatment with antiarrhythmic drugs after cardioversion. The Gap-AF trial investigates the impact of complete pulmonary vein (PV) isolation versus incomplete circumferential PV ablation on AF recurrences. The effect of preventive pacing on the recurrence of paroxysmal AF is studied in the BACE-PACE trial.

AB - The German Competence Network on Atrial Fibrillation (AFNET) is an interdisciplinary national research network funded by the Federal Ministry of Education and Research (BMBF) since 2003. The AFNET aims at improving treatment of atrial fibrillation (AF), the most frequent sustained arrhythmia of the heart. The AFNET has established a nationwide patient registry on manifestation, diagnostics, and therapy of AF in Germany. The data analyzed to date demonstrate that patients with AF are likely to have multiple comorbidities (hypertension, valvular heart disease, coronary artery disease, diabetes mellitus) and an advanced age. Regarding oral anticoagulation, guideline adherence is very high. Basic research has identified specific changes in atrial tissue during AF-induced remodeling providing the rationale for novel therapeutic interventions. Clinical trials are being carried out to optimize pharmacological and nonpharmacological treatments. The ANTIPAF trial is designed to prove that angiotensin II receptor blockers reduce the incidence of paroxysmal AF. The Flec-SL trial tests the efficacy of a short-term treatment with antiarrhythmic drugs after cardioversion. The Gap-AF trial investigates the impact of complete pulmonary vein (PV) isolation versus incomplete circumferential PV ablation on AF recurrences. The effect of preventive pacing on the recurrence of paroxysmal AF is studied in the BACE-PACE trial.

KW - Atrial Fibrillation/diagnosis

KW - Community Networks/organization & administration

KW - Germany/epidemiology

KW - Humans

KW - National Health Programs/organization & administration

KW - Population Surveillance

KW - Practice Patterns, Physicians'/statistics & numerical data

KW - Professional Competence/statistics & numerical data

KW - Registries

U2 - 10.1007/s00059-008-3177-2

DO - 10.1007/s00059-008-3177-2

M3 - SCORING: Journal article

C2 - 19137244

VL - 33

SP - 548

EP - 555

JO - HERZ

JF - HERZ

SN - 0340-9937

IS - 8

ER -